Dialysis specialist FMC tops quarterly core profit forecast

Reuters11-05

Nov 5 (Reuters) - World's largest dialysis specialist Fresenius Medical Care reported third-quarter operating profit above market expectations on Tuesday, helped by additional savings from its FME25 transformation programme.

The German company said its adjusted operating income grew 42.7% to 463 million euros ($504 million) in the July-September period, versus analysts' median estimate of 434 million euros in a company-provided consensus.

Fresenius Medical Care expects its full-year operating income to grow by 16% to 18% compared to prior year. Previously, it had forecast a mid- to high-teens percentage growth rate. ($1 = 0.9192 euros)

(Reporting by Bartosz Dabrowski in Gdansk; editing by Milla Nissi)

((bartosz.dabrowski@thomsonreuters.com; +48 58 7696560;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2481023548?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-05 14:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2481023548","market":"us","top_or_hot":-1,"title":"Dialysis specialist FMC tops quarterly core profit forecast","media":"Reuters","content":"<html><body><p>Nov 5 (Reuters) - World's largest dialysis specialist Fresenius Medical Care    reported third-quarter operating profit above market expectations on Tuesday, helped by additional savings from its FME25 transformation programme.</p><p>   The German company said its adjusted operating income grew 42.7% to 463 million euros ($504 million) in the July-September period, versus analysts' median estimate of 434 million euros in a company-provided consensus.</p><p>   Fresenius Medical Care expects its full-year operating income to grow by 16% to 18% compared to prior year. Previously, it had forecast a mid- to high-teens percentage growth rate. ($1 = 0.9192 euros)</p><p> (Reporting by Bartosz Dabrowski in Gdansk; editing by Milla Nissi)</p><p>((bartosz.dabrowski@thomsonreuters.com; +48 58 7696560;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dialysis specialist FMC tops quarterly core profit forecast</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDialysis specialist FMC tops quarterly core profit forecast\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-05 14:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nov 5 (Reuters) - World's largest dialysis specialist Fresenius Medical Care    reported third-quarter operating profit above market expectations on Tuesday, helped by additional savings from its ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FMC","symbol_name":"FMC Corp.","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2481023548","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2481023548","pubTimestamp":1730786446,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Nov 5  - World's largest dialysis specialist Fresenius Medical Care    reported third-quarter operating profit above market expectations on Tuesday, helped by additional savings from its FME25 transformation programme.   The German company said its adjusted operating income grew 42.7% to 463 million euros  in the July-September period, versus analysts' median estimate of 434 million euros in a company-provided consensus.   Fresenius Medical Care expects its full-year operating income to grow by 16% to 18% compared to prior year. Previously, it had forecast a mid- to high-teens percentage growth rate.  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"FMC":"FMC Corp.","BK4545":"锂电池","LU0471298777.SGD":"Blackrock Nutrition A2 SGD-H","BK4585":"ETF&股票定投概念","BK4588":"碎股","LU0385154629.USD":"贝莱德营养科学基金A2","BK4093":"化肥与农用药剂"},"translate_title":"透析专家FMC高于季度核心利润预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FMC":1},"content_text":"Nov 5 (Reuters) - World's largest dialysis specialist Fresenius Medical Care    reported third-quarter operating profit above market expectations on Tuesday, helped by additional savings from its FME25 transformation programme.   The German company said its adjusted operating income grew 42.7% to 463 million euros ($504 million) in the July-September period, versus analysts' median estimate of 434 million euros in a company-provided consensus.   Fresenius Medical Care expects its full-year operating income to grow by 16% to 18% compared to prior year. Previously, it had forecast a mid- to high-teens percentage growth rate. ($1 = 0.9192 euros) (Reporting by Bartosz Dabrowski in Gdansk; editing by Milla Nissi)((bartosz.dabrowski@thomsonreuters.com; +48 58 7696560;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481023548"}